Marylyn M. Addo

21.6k total citations · 1 hit paper
223 papers, 10.0k citations indexed

About

Marylyn M. Addo is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Marylyn M. Addo has authored 223 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 67 papers in Immunology and 62 papers in Virology. Recurrent topics in Marylyn M. Addo's work include HIV Research and Treatment (56 papers), Immune Cell Function and Interaction (56 papers) and SARS-CoV-2 and COVID-19 Research (40 papers). Marylyn M. Addo is often cited by papers focused on HIV Research and Treatment (56 papers), Immune Cell Function and Interaction (56 papers) and SARS-CoV-2 and COVID-19 Research (40 papers). Marylyn M. Addo collaborates with scholars based in Germany, United States and United Kingdom. Marylyn M. Addo's co-authors include Marcus Altfeld, Bruce D. Walker, Eric Rosenberg, Philip Goulder, Christian Brander, Mary N. Johnston, Xu G. Yu, Robert L. Eldridge, Rika Draenert and Daryld Strick and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Marylyn M. Addo

214 papers receiving 9.8k citations

Hit Papers

Comprehensive Epitope Analysis of Human Immunodeficiency ... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marylyn M. Addo Germany 53 5.0k 4.6k 3.1k 1.8k 1.7k 223 10.0k
Suzanne M. Crowe Australia 60 7.0k 1.4× 5.7k 1.2× 4.8k 1.5× 2.5k 1.4× 3.4k 1.9× 265 15.0k
Jean‐Pierre Routy Canada 60 8.5k 1.7× 5.8k 1.3× 6.1k 2.0× 2.1k 1.2× 2.9k 1.7× 366 14.4k
Galit Alter United States 68 5.1k 1.0× 9.6k 2.1× 5.3k 1.7× 3.1k 1.7× 3.0k 1.7× 310 16.6k
Neeltje A. Kootstra Netherlands 45 4.7k 0.9× 3.0k 0.7× 3.2k 1.0× 2.0k 1.1× 1.8k 1.0× 202 8.3k
Miles P. Davenport Australia 54 2.3k 0.5× 4.7k 1.0× 4.3k 1.4× 2.0k 1.1× 1.8k 1.1× 256 10.8k
Tao Dong United Kingdom 52 3.9k 0.8× 6.5k 1.4× 3.4k 1.1× 2.1k 1.2× 3.3k 1.9× 245 11.6k
Christian Brander United States 63 7.6k 1.5× 7.7k 1.7× 3.4k 1.1× 3.2k 1.8× 2.9k 1.7× 242 13.5k
Roger Le Grand France 46 2.7k 0.5× 2.8k 0.6× 2.8k 0.9× 1.4k 0.8× 1.6k 0.9× 283 7.7k
Benigno Rodríguez United States 46 6.6k 1.3× 3.6k 0.8× 4.6k 1.5× 1.1k 0.6× 3.0k 1.7× 149 11.0k
Jacob D. Estes United States 54 6.0k 1.2× 4.8k 1.0× 3.2k 1.0× 1.5k 0.8× 2.3k 1.3× 137 10.1k

Countries citing papers authored by Marylyn M. Addo

Since Specialization
Citations

This map shows the geographic impact of Marylyn M. Addo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marylyn M. Addo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marylyn M. Addo more than expected).

Fields of papers citing papers by Marylyn M. Addo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marylyn M. Addo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marylyn M. Addo. The network helps show where Marylyn M. Addo may publish in the future.

Co-authorship network of co-authors of Marylyn M. Addo

This figure shows the co-authorship network connecting the top 25 collaborators of Marylyn M. Addo. A scholar is included among the top collaborators of Marylyn M. Addo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marylyn M. Addo. Marylyn M. Addo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mellinghoff, Sibylle C., Martin Thelen, Michael von Bergwelt‐Baildon, et al.. (2025). Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option. Mycoses. 68(3). e70044–e70044. 2 indexed citations
2.
Addo, Marylyn M., et al.. (2025). Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women. Seminars in Immunopathology. 47(1). 25–25. 1 indexed citations
3.
Mellinghoff, Sibylle C., Sandra Robrecht, Rosanne Sprute, et al.. (2024). Hybrid immunity to SARS‐CoV ‐2 in patients with chronic lymphocytic leukemia. European Journal Of Haematology. 112(5). 788–793.
4.
Mayer, Leonie, et al.. (2024). Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. Signal Transduction and Targeted Therapy. 9(1). 327–327. 5 indexed citations
5.
Raadsen, Matthijs P., Mariana Garcı́a, Till Koch, et al.. (2024). Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach. iScience. 27(8). 110470–110470. 1 indexed citations
6.
Lütgehetmann, Marc, Sven Pischke, Felix Piecha, et al.. (2024). High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study. United European Gastroenterology Journal. 12(3). 339–351. 1 indexed citations
7.
Mayer, Leonie, Anahita Fathi, Maya Kono, et al.. (2024). MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans. npj Vaccines. 9(1). 20–20. 3 indexed citations
8.
Prajeeth, Chittappen Kandiyil, Friederike Twele, Sebastian Meller, et al.. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training. Journal of Virological Methods. 317. 114733–114733. 1 indexed citations
9.
Raadsen, Matthijs P., Christine Dahlke, Anahita Fathi, et al.. (2023). Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein. The Journal of Infectious Diseases. 228(5). 586–590. 8 indexed citations
10.
Fathi, Anahita, Christine Dahlke, Jörg D. Hoheisel, et al.. (2023). Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease. SHILAP Revista de lepidopterología. 3(1). 51–51. 7 indexed citations
11.
Kayange, Neema, Britta Gröndahl, Adolfine Hokororo, et al.. (2023). Challenges in Diagnosing and Treating Acutely Febrile Children with Suspected Malaria at Health Care Facilities in the Lake Mwanza Region of Tanzania. American Journal of Tropical Medicine and Hygiene. 110(2). 202–208. 4 indexed citations
12.
Florey, M. E., Ulf Schulze‐Sturm, Marc Lütgehetmann, et al.. (2023). High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022. Infection. 51(5). 1569–1575. 1 indexed citations
13.
Hennigs, Jan K., Tim Oqueka, Marcel Simon, et al.. (2022). Respiratory muscle dysfunction in long-COVID patients. Infection. 50(5). 1391–1397. 30 indexed citations
14.
Brehm, Thomas Theo, Till F. Omansen, Stefan Schmiedel, et al.. (2022). High‐resolution analysis of individual spike peptide‐specific CD4+ T‐cell responses in vaccine recipients and COVID‐19 patients. Clinical & Translational Immunology. 11(8). e1410–e1410. 8 indexed citations
15.
Woo, Marcel S., Thomas Theo Brehm, Marlene Fischer, et al.. (2022). Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study. Microbiology Spectrum. 11(1). e0410322–e0410322. 4 indexed citations
16.
Brehm, Thomas Theo, Sabine Jordan, Marylyn M. Addo, Michael Ramharter, & Benno Kreuels. (2021). Attitudes, practices, and obstacles towards influenza vaccination for international travelers among travel health advisors in Germany: A questionnaire-based survey. Travel Medicine and Infectious Disease. 45. 102233–102233. 1 indexed citations
17.
Brehm, Thomas Theo, Dorothee Schwinge, Marylyn M. Addo, et al.. (2021). Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic. International Journal of Hygiene and Environmental Health. 238. 113851–113851. 11 indexed citations
18.
Cham, Lamin B., Vikas Duhan, Dieter Häussinger, et al.. (2020). Usp18 Expression in CD169+ Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV. Vaccines. 8(1). 142–142. 4 indexed citations
19.
Brehm, Thomas Theo, Dorothee Schwinge, Samuel Huber, et al.. (2020). Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. International Journal of Hygiene and Environmental Health. 232. 113671–113671. 28 indexed citations
20.
Addo, Marylyn M., Xu G. Yu, Eric Rosenberg, Bruce D. Walker, & Marcus Altfeld. (2002). Cytotoxic T-Lymphocyte (CTL) Responses Directed against Regulatory and Accessory Proteins in HIV-1 Infection. DNA and Cell Biology. 21(9). 671–678. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026